Table 1 Clinicopathological features of 47 postoperative patients with recurrent and non-recurrent PanNETs
Non-recurrent PanNETs | Recurrent PanNETs | All** | ||
|---|---|---|---|---|
Age ,median, years | 51.5 | 49 | 50 | |
Gender, n (%) | Male | 9(22.0) | 5(12.2) | 17(36.2) |
Female | 15(36.6) | 12(29.3) | 30(63.8) | |
Tumor function, n (%) | Functional | 5(12.2) | 2(4.9) | 9(19.1) |
Non-functional | 19 (46.3) | 15(36.6) | 38(80.9) | |
Tumor location, n (%) | Body and tail | 6(14.6) | 9(22.0) | 17(36.2) |
Head | 9(22.0) | 5(12.2) | 17(36.2) | |
Body | 3(7.3) | 0(0.0) | 4(8.5) | |
Tail | 6(14.6) | 3(7.3) | 9(19.1) | |
Tumor size, median (cm) | 5 | 8.2 | 3.65 | |
T | T1 | 7(18.4) | 0(0.0) | 9(19.1) |
T2 | 10(26.3) | 6(15.8) | 20(42.6) | |
T3 | 7(18.4) | 8(21.1) | 15(31.9) | |
N (lymph nodes status), n (%) | Negative (N0) | 19(47.5) | 10(25.0) | 34(72.3) |
Positive (N1) | 5(12.5) | 6(15.0) | 12(25.5) | |
Stage, n (%) | IA | 7(18.4) | 0(0.0) | 9(19.1) |
IB | 9(23.7) | 2(5.3) | 14(29.8) | |
IIA | 4(10.5) | 3(7.9) | 7(14.9) | |
IIB | 4(10.5) | 9(23.7) | 14(29.8) | |
Grade, n (%) | G1 | 6(14.6) | 2(4.9) | 14(29.8) |
G2 | 18(43.9) | 15(36.6) | 33(70.2) | |
Ki67 index, median,% | 5 | 8.2 | 5 | |
Ki67 index | ≥ 10% | 5(12.2) | 3(7.3) | 39(83.0) |
< 10% | 21(51.2) | 12(29.3) | 8(17.0) | |
Vascular invasion, n (%) | Positive | 1(2.6) | 6(15.4) | 7(14.9) |
Negative | 23(59.0) | 9(23.1) | 38(80.9) | |
Perineural invasion, n (%) | Positive | 0(0.0) | 4(10.0) | 4(8.5) |
Negative | 24(60.0) | 12(30.0) | 42(89.4) | |
Margin status, n (%) | Positive | 2(5.0) | 6(15.0) | 8(17.0) |
Negative | 22(55.0) | 10(25.0) | 38(80.9) | |
Localized or regional stage tumors, n (%) | Regional | 8(20.0) | 14(35.0) | 23(48.9) |
Localized | 16(40.0) | 2(5.0) | 23(48.9) | |